Toothless Tottenham were booed off as Chelsea recorded a fifth straight win over their London rivals, with Joao Pedro’s first ...
The £115m price tag had seemed to hang around his neck like a glittering weight in his early days at Chelsea but we're now ...
The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.
An expert said weight loss drugs might help people see faster results, which can give them encouragement to continue. But he ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
The bathroom scales continue to be an opponent some Americans can’t defeat. The Centers for Disease Control and Prevention ...
Opinion
2don MSNOpinion
MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart
Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC antitrust review and regulatory scrutiny.
The company has $400 million, enough cash to potentially build off results from an early-stage leukemia yet this quarter.
Working out at least five days a week for the past three years, Ono shed more than 100 pounds. She credits heavy lifting, cardio and giving herself grace when it comes to cheat meals.
Opinion
1dOpinion
GLP-1s may not be a solution for our obesity crisis. But limiting access to these weight-loss medications is not the answer.
As health insurance companies pull back on their coverage, R.I. needs to look for ways to buy in bulk and adopt a new health strategy, write doctors at the Rhode Island Public Health Institute.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback